Search research articles
Contact Us
Filters
Showing results (331-340 of 369) with videos related to
Page
of 37
Sort By:
Neuro-Oncology
|
December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannoma
Simone Schmid, Kanish Mirchia, Anna Tietze, et al.
American Journal of Human Genetics
|
March 7, 2020
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification
Lucia V Schottlaender, Rosella Abeti, Zane Jaunmuktane, et al.
Acta Neuropathologica
|
December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1
Philipp Sievers, Martin Sill, Christina Blume, et al.
Neuro-Oncology
|
January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant
Emilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Journal of Alzheimer'S Disease : JAD
|
March 12, 2016
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Natalia Lelental, Sebastian Brandner, Olga Kofanova, et al.
Acta Neuropathologica
|
April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica
|
February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA
Yanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2025
The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations
Rita Pereira, Alan Mackay, Yura Grabovska, et al.
American Journal of Human Genetics
|
December 3, 2014
Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2
Ellen Cottenie, Andrzej Kochanski, Albena Jordanova, et al.
Neuro-Oncology
|
April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
Philipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 369) with videos related to
Sort By:
Page
of 37
Neuro-Oncology
|
December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannoma
Simone Schmid, Kanish Mirchia, Anna Tietze, et al.
American Journal of Human Genetics
|
March 7, 2020
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification
Lucia V Schottlaender, Rosella Abeti, Zane Jaunmuktane, et al.
Acta Neuropathologica
|
December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1
Philipp Sievers, Martin Sill, Christina Blume, et al.
Neuro-Oncology
|
January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant
Emilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Journal of Alzheimer'S Disease : JAD
|
March 12, 2016
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Natalia Lelental, Sebastian Brandner, Olga Kofanova, et al.
Acta Neuropathologica
|
April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica
|
February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA
Yanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2025
The spectrum of IDH- and H3-wildtype high-grade glioma subgroups occurring across teenage and young adult patient populations
Rita Pereira, Alan Mackay, Yura Grabovska, et al.
American Journal of Human Genetics
|
December 3, 2014
Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2
Ellen Cottenie, Andrzej Kochanski, Albena Jordanova, et al.
Neuro-Oncology
|
April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
Philipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Page
of 37